These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22488221)

  • 41. The kidney, hypertension, and obesity.
    Hall JE
    Hypertension; 2003 Mar; 41(3 Pt 2):625-33. PubMed ID: 12623970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity hypertension, salt sensitivity and insulin resistance.
    Rocchini AP
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obesity, kidney dysfunction and hypertension: mechanistic links.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Nat Rev Nephrol; 2019 Jun; 15(6):367-385. PubMed ID: 31015582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of Aldosterone in Obesity-Related Hypertension.
    Kawarazaki W; Fujita T
    Am J Hypertens; 2016 Apr; 29(4):415-23. PubMed ID: 26927805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving obesity and blood pressure.
    Tanaka M
    Hypertens Res; 2020 Feb; 43(2):79-89. PubMed ID: 31649313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
    Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
    Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypertension in obese patients: Pathophysiology and management].
    Girerd X; Hansel B
    Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
    Itoh H
    Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of hypertension in obese patients].
    Comte-Perret S; Giusti V; Wuerzner G
    Rev Med Suisse; 2013 Sep; 9(397):1622, 1624-6. PubMed ID: 24073473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic disturbances linked to obesity: the role of impaired tissue perfusion.
    Villela NR; Kramer-Aguiar LG; Bottino DA; Wiernsperger N; Bouskela E
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):238-45. PubMed ID: 19466216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathways from obesity to hypertension: from the perspective of a vicious triangle.
    Montani JP; Antic V; Yang Z; Dulloo A
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 2():S28-38. PubMed ID: 12174326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
    Dorresteijn JA; Schrover IM; Visseren FL; Scheffer PG; Oey PL; Danser AH; Spiering W
    J Hypertens; 2013 Feb; 31(2):393-403. PubMed ID: 23235355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Arterial hypertension in patients with obesity. Role of hyperinsulinism and insulin resistance].
    Feraille E; Krempf M; Charbonnel B; Bouhour JB; Nicolas G
    Rev Med Interne; 1990; 11(4):293-6. PubMed ID: 2096434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular oxidative stress is associated with insulin resistance in hyper-reninemic nonmodulating essential hypertension.
    Sanchez R; Fischer P; Cuniberti L; Masnatta LD; Ramírez AJ
    J Hypertens; 2007 Dec; 25(12):2434-40. PubMed ID: 17984665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension.
    Modan M; Halkin H
    Diabetes Care; 1991 Jun; 14(6):470-87. PubMed ID: 1864220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertension and obesity.
    Aneja A; El-Atat F; McFarlane SI; Sowers JR
    Recent Prog Horm Res; 2004; 59():169-205. PubMed ID: 14749502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
    Landsberg L
    J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sympathetic nervous system and endothelial function in heart failure].
    Binggeli C; Wenzel RR; Noll G
    Praxis (Bern 1994); 1996 Feb; 85(8):234-44. PubMed ID: 8701190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sleep apnea, aldosterone, and resistant hypertension.
    Pimenta E; Calhoun DA; Oparil S
    Prog Cardiovasc Dis; 2009; 51(5):371-80. PubMed ID: 19249443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
    Carlson SH; Shelton J; White CR; Wyss JM
    Hypertension; 2000 Jan; 35(1 Pt 2):403-8. PubMed ID: 10642332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.